Flexion Therapeutics taps anesthesiologist Dr. Scott Kelley for CMO position — 3 insights

Written by Eric Oliver | December 13, 2017 | Print  |

Flexion Therapeutics' next CMO will be anesthesiologist Scott Kelley, MD.

Here's what you should know:

1. Dr. Kelley previously served as the company's vice president of medical affairs.

2. In this new position, Dr. Kelley will assume responsibility for all of Flexion Therapeutics' medical matters.

3. Before joining Flexion in May 2016, Dr. Kelley was Sanofi's vice president of global medical affairs. At Sanofi, he oversaw global data generation, data dissemination and served as a key opinion leader.

Flexion CEO Michael Clayman, MD, said, "Scott has demonstrated a singular combination of rigor and creativity with respect to clinical trial design, clinical data analysis and the consideration of pipeline candidates, and he melds those skills with an innate ability to communicate ideas and data with passion and clarity. … We look forward to his continued success in his expanded role at this critical juncture in the company’s evolution."

More articles on anesthesia:
Ancillary procedure payments cut under 2018 CMS Physician Fee Schedule — 5 insights
New Jersey Monthly names NAPA partner Dr. Jonathan Markley a top doctor — 4 insights
Anesthesia Business Consultants attends 71st Annual PostGraduate Assembly in Anesthesiology — 4 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.